Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis

Efstathios Kastritis, Xavier Leleu, Bertrand Arnulf, Elena Zamagni, María Teresa Cibeira, Fiona Kwok, Peter Mollee, Roman Hájek, Philippe Moreau, Arnaud Jaccard, Stefan O Schönland, Robin Filshie, Emmanuelle Nicolas-Virelizier, Bradley Augustson, María-Victoria Mateos, Ashutosh Wechalekar, Eric Hachulla, Paolo Milani, Meletios A Dimopoulos, Jean-Paul FermandAndrea Foli, Maria Gavriatopoulou, Catherine Klersy, Antonio Palumbo, Pieter Sonneveld, Hans Erik Johnsen, Giampaolo Merlini, Giovanni Palladini

Research output: Contribution to journalJournal articleResearchpeer-review

4 Citations (Scopus)
Original languageEnglish
JournalJournal of Clinical Oncology
Volume38
Issue number28
Pages (from-to)3252-3260
Number of pages9
ISSN0732-183X
DOIs
Publication statusPublished - 1 Oct 2020

Fingerprint Dive into the research topics of 'Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis'. Together they form a unique fingerprint.

Cite this